Abbiamo trovato la persona più indicata per opporre la richiesta di archiviazione per il ricatto vaccinale presso il Tribunale di Genova. Vi ringrazio per la massiccia adesione a questa battaglia. Nei prossimi giorni pubblicherò l’atto di opposizione depositato ed in udienza venderemo cara la pelle! Non molliamo.
169 comments
Log in to comment
parole di ricerca:
lipid nanoparticels PF-07305885 Bnt 162b2
Presenza Ossido di
Grafene Oxide = GP
Al paragrafo 5.2 del Safety Data Sheet (Foglio dei Dati di
Sicurezza – Fonte -1 in calce all’articolo) del
Pfizer-BioNTech COVID-19 Vaccine si legge questo in relazione ai
“Pericoli speciali derivanti dalla sostanza o dalla miscela” che
rientra nella Famiglia Chimica delle “Nanoparticelle lipidiche
contenenti PF-07305885 (BNT162b2) e lipidi”.
Vaccine
- SAFETY DATA SHEET - Pfizer
https://safetydatasheets.pfizer.com
› Document
PDF
7 dic 2021 — Lipid Nanoparticles
containing PF-07305885 (BNT162b2) and
Lipids. 1.2. Relevant identified uses of the substance or
mixture and uses advised ...
La
prima pagina del Safety Data Sheet di Pfizer-Biontech su Comirnatylink
sito:
https://www.databaseitalia.it/vaccini-grafene-3-pericolose-nanoparticelle-nel-siero-mrna-x-file-pfizer-shock-tossicologia-non-studiata-a-fondo/
https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125-pi.pdf
- Version:
pfpcovii50121
Supersedes:
N/A
Page
1
of
15
Attachment
1: AusPAR
– COMIRNATY
-
BNT162b2
(mRNA)
-
Pfizer
Australia Pty Ltd -
PM-2020-05461-1-2
FINAL
25 January 2021. This is the Product Information that was approved
with the submission described in
this
AusPAR. It may have been superseded. For the most recent PI, please
refer to the TGA website
at
<https://www.tga.gov.au/product-information-pi>
▼This
vaccine is subject to additional monitoringin
Australia. This will allow quick
identification
of new safety information. Healthcare professionals are asked to
report any suspected adverse events atwww.tga.gov.au/reporting-problems.
AUSTRALIANPRODUCTINFORMATION
–
COMIRNATY™(BNT162b2[mRNA])COVID-19
VACCINE
1. N
AME OF THE MEDICINE
BNT162b2 [mRNA]
2. QUALITATIVE AND
QUANTITATIVE COMPOSITIONThis
is a multidose vial and must be diluted before use.One
vial (0.45 mL) contains 6 doses of 0.3 mL after dilution, see
Sections 4.2 and 6.6.1dose
(0.3 mL) contains 30 micrograms of BNT162b2
[mRNA] (embedded in lipidnanoparticles).The
active ingredient is a single-stranded, 5’-capped messenger RNA
(mRNA) produced usinga
cell-freein
vitrotranscription
from the corresponding DNA templates, encoding the viralspike
(S) protein of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2).For
the full list of excipients, see Section 6.1 List of excipients.....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442307/
-Public health information
(CDC) Research information
(NIH) SARS-CoV-2
data (NCBI) Journal
List
Elsevier
Public Health Emergency Collection
PMC8442307
Graphene-based
nanomaterials as antimicrobial surface coatings: A parallel approach
to restrain the expansion of COVID-19.
foto:https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/wm-pheelsevier.gif.
How
the Graphene Could Help to Decrease SARS-CoV-2 ...
https://pp.bme.hu
› article › download
PDF
Presenza Ossido di
Grafene Oxide = GP
Al paragrafo 5.2 del Safety Data Sheet (Foglio dei Dati di
Sicurezza – Fonte -1 in calce all’articolo) del
Pfizer-BioNTech COVID-19 Vaccine si legge questo in relazione ai
“Pericoli speciali derivanti dalla sostanza o dalla miscela” che
rientra nella Famiglia Chimica delle “Nanoparticelle lipidiche
contenenti PF-07305885 (BNT162b2) e lipidi”.
Vaccine
- SAFETY DATA SHEET - Pfizer
https://safetydatasheets.pfizer.com
› Document
PDF
7 dic 2021 — Lipid Nanoparticles
containing PF-07305885 (BNT162b2) and
Lipids. 1.2. Relevant identified uses of the substance or
mixture and uses advised ...